SCHEMBL1286485

SCHEMBL1286485

CC(C)(C)C(O)(CCCCOc1ccccc1Cl)Cn1cncn1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
CYP3A4 P08684 1/20 0.57
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 2/20 0.46
KMT2A Q03164 3/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 2/20 0.43
USP2 O75604 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSP90AA1 P07900 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALOX15 P16050 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1286480 0.87 ALDH1A1 (0.60) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL2128040 0.87 MAPK1 (0.63) ALDH1A1CYP3A4KDM4EMAPK1KMT2A
SCHEMBL1282665 0.84 ALDH1A1 (0.55) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL10392892 0.83 ALDH1A1 (0.61) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL1286436 0.81 CYP3A4 (0.52) ALDH1A1CYP3A4KDM4EMAPK1KMT2A
SCHEMBL1286469 0.81 ALDH1A1 (0.57) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL10360988 0.80 ALDH1A1 (0.56) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL10391870 0.79 ALDH1A1 (0.68) ALDH1A1CYP3A4KDM4EKMT2ATSHR
SCHEMBL3744681 0.79 CYP3A4 (0.68) ALDH1A1CYP3A4KDM4EKMT2AMEN1
SCHEMBL10937463 0.79 ALDH1A1 (0.45) ALDH1A1CYP3A4KDM4EMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443098-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2012-04-25 EP disclosed
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-04-12 US disclosed
WO-2010146112-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088660-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 ALDH1A1 1943/4885CYP3A4 19/4885KDM4E 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.